Stability and oligomeric equilibria of refolded interleukin-1 beta converting enzyme

被引:32
|
作者
Talanian, RV
Dang, LC
Ferenz, CR
Hackett, MC
Mankovich, JA
Welch, JP
Wong, WW
Brady, KD
机构
[1] BASF Bioresearch Corporation, Worcester
关键词
D O I
10.1074/jbc.271.36.21853
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report the preparation and characterization of interleukin-1 beta converting enzyme (ICE) refolded from its p20 and p10 protein fragments, Refolded ICE heterodimer (p20p10) was catalytically active but unstable, and in size exclusion chromatography eluted at an apparent molecular mass of 30 kDa, The mechanisms of the observed instability were pH-dependent dissociation at low enzyme concentrations, and autolytic degradation of the p10 subunit at high concentrations, Binding and subsequent removal of a high affinity peptidic inhibitor increased the apparent molecular mass to 43 kDa (by size exclusion chromatography), and significantly increased its stability and specific activity. Chemical cross-linking and SDS-polyacrylamide gel electrophoresis analysis of the 43-kDa size exclusion chromatography conformer revealed a 60-kDa species, which was absent in the 30-kDa conformer, suggesting that inhibitor binding caused formation of a (p20p10), homodimer, The observation of a reversible equilibrium between ICE (p20p10) and (p20p10)(2) suggests that analogous associations, possibly between ICE and ICE homologs, can occur in vivo, resulting in novel oligomeric protease species.
引用
收藏
页码:21853 / 21858
页数:6
相关论文
共 50 条
  • [1] Stability and oligomeric equilibria of refolded interleukin-1 beta converting enzyme (vol 271, pg 21853, 1996)
    Talanian, RV
    Dang, LC
    Ferenz, CR
    Hackett, MC
    Mankovich, JA
    Welch, JP
    Wong, WW
    Brady, KD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 1412 - 1412
  • [2] The design of inhibitors of interleukin-1 beta converting enzyme (ICE)
    Murcko, MA
    FASEB JOURNAL, 2000, 14 (08): : A1309 - A1309
  • [3] Characterization of mice deficient in interleukin-1 beta converting enzyme
    Li, P
    Allen, H
    Banerjee, S
    Seshadri, T
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1997, 64 (01) : 27 - 32
  • [4] The interleukin-1 beta converting enzyme family of cysteine proteases
    Miller, DK
    Myerson, J
    Becker, JW
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1997, 64 (01) : 2 - 10
  • [5] Role of interleukin-1 beta converting enzyme (ICE) in leukemia
    Estrov, Z
    Talpaz, M
    CYTOKINES AND MOLECULAR THERAPY, 1996, 2 (01): : 1 - 11
  • [6] Interleukin-1β, interleukin-18, and the interleukin-1β converting enzyme
    Dinarello, CA
    MOLECULAR MECHANISMS OF FEVER, 1998, 856 : 1 - 11
  • [7] Functional characterization of the prodomain of interleukin-1 beta-converting enzyme
    VanCriekinge, W
    Beyaert, R
    VandeCraen, M
    Vandenabeele, P
    Schotte, P
    DeValck, D
    Fiers, W
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) : 27245 - 27248
  • [8] Peptidic ketones as interleukin-1 beta-converting enzyme inhibitors
    Sterling Winthrop Inc, King of Prussia, United States
    Biotechnol Adv, 3-4 (756):
  • [9] First examples of peptidomimetic inhibitors of interleukin-1 beta converting enzyme
    Dolle, RE
    Prouty, CP
    Prasad, CVC
    Cook, E
    Saha, A
    Ross, TM
    Salvino, JM
    Helaszek, CT
    Ator, MA
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (13) : 2438 - 2440
  • [10] 4-hydroxynonenal inhibits interleukin-1 beta converting enzyme
    Davis, DW
    Hamilton, RF
    Holian, A
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 (04): : 205 - 210